本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

26.94
-0.8400-3.02%
盤後26.940.00000.00%19:43 EDT
成交量:56.20萬
成交額:1,520.04萬
市值:19.66億
市盈率:-114.32
高:27.71
開:27.52
低:26.56
收:27.78
資料載入中...
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/23

重要事件披露

Form 8-K - Current report
2025/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities